Fina Lovren

3.4k total citations
45 papers, 2.7k citations indexed

About

Fina Lovren is a scholar working on Physiology, Cardiology and Cardiovascular Medicine and Molecular Biology. According to data from OpenAlex, Fina Lovren has authored 45 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Physiology, 17 papers in Cardiology and Cardiovascular Medicine and 12 papers in Molecular Biology. Recurrent topics in Fina Lovren's work include Nitric Oxide and Endothelin Effects (14 papers), Adipokines, Inflammation, and Metabolic Diseases (6 papers) and Eicosanoids and Hypertension Pharmacology (5 papers). Fina Lovren is often cited by papers focused on Nitric Oxide and Endothelin Effects (14 papers), Adipokines, Inflammation, and Metabolic Diseases (6 papers) and Eicosanoids and Hypertension Pharmacology (5 papers). Fina Lovren collaborates with scholars based in Canada, Saudi Arabia and United States. Fina Lovren's co-authors include Subodh Verma, Hwee Teoh, Adrian Quan, Chris R. Triggle, Mohammed Al‐Omran, Praphulla Chandra Shukla, Krishna K. Singh, Yi Pan, Milan Gupta and Paul E. Szmitko and has published in prestigious journals such as Journal of Biological Chemistry, Circulation and Nature Communications.

In The Last Decade

Fina Lovren

44 papers receiving 2.7k citations

Peers

Fina Lovren

CCM

PHYSI

EPIDE

Masahiko Igarashi Japan

Edith Hochhauser Israel

Thomas C. Wascher Austria

Giulio Ceolotto Italy

Marshall A. Corson United States

Tomohiro Osanai Japan

Hartmut Ruetten Germany

Katalin Kauser United States

Xiangru Lu Canada

Yukio Hara Japan

Masahiko Igarashi Japan

Fina Lovren

1.2k ×1.3

596 ×0.8

CCM

843 ×1.1

PHYSI

683 ×1.2

EPIDE

309 ×0.9

Citations per year, relative to Fina Lovren Fina Lovren (= 1×) peers Masahiko Igarashi

Countries citing papers authored by Fina Lovren

Since Specialization

Citations

This map shows the geographic impact of Fina Lovren's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fina Lovren with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fina Lovren more than expected).

Fields of papers citing papers by Fina Lovren

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fina Lovren. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fina Lovren. The network helps show where Fina Lovren may publish in the future.

Co-authorship network of co-authors of Fina Lovren

This figure shows the co-authorship network connecting the top 25 collaborators of Fina Lovren. A scholar is included among the top collaborators of Fina Lovren based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fina Lovren. Fina Lovren is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Lovren, Fina, Hwee Teoh, & Subodh Verma. (2014). Obesity and Atherosclerosis: Mechanistic Insights. Canadian Journal of Cardiology. 31(2). 177–183. 161 indexed citations

Singh, Krishna K., Fina Lovren, Yi Pan, et al.. (2014). The Essential Autophagy Gene ATG7 Modulates Organ Fibrosis via Regulation of Endothelial-to-Mesenchymal Transition. Journal of Biological Chemistry. 290(5). 2547–2559. 96 indexed citations

Singh, Krishna K., Praphulla Chandra Shukla, Adrian Quan, et al.. (2013). BRCA1 is a novel target to improve endothelial dysfunction and retard atherosclerosis. Journal of Thoracic and Cardiovascular Surgery. 146(4). 949–960.e4. 54 indexed citations

Singh, Krishna K., Praphulla Chandra Shukla, Bobby Yanagawa, et al.. (2013). Regulating cardiac energy metabolism and bioenergetics by targeting the DNA damage repair protein BRCA1. Journal of Thoracic and Cardiovascular Surgery. 146(3). 702–709. 22 indexed citations

Singh, Krishna K., Bobby Yanagawa, Adrian Quan, et al.. (2013). Autophagy gene fingerprint in human ischemia and reperfusion. Journal of Thoracic and Cardiovascular Surgery. 147(3). 1065–1072.e1. 42 indexed citations

Teoh, Hwee, Adrian Quan, K. W. Annie Bang, et al.. (2012). BRCA1 gene therapy reduces systemic inflammatory response and multiple organ failure and improves survival in experimental sepsis. Gene Therapy. 20(1). 51–61. 21 indexed citations

Shukla, Praphulla Chandra, Krishna K. Singh, Adrian Quan, et al.. (2011). BRCA1 is an essential regulator of heart function and survival following myocardial infarction. Nature Communications. 2(1). 593–593. 115 indexed citations

Singh, Krishna K., Praphulla Chandra Shukla, Adrian Quan, et al.. (2011). BRCA2 Protein Deficiency Exaggerates Doxorubicin-induced Cardiomyocyte Apoptosis and Cardiac Failure. Journal of Biological Chemistry. 287(9). 6604–6614. 44 indexed citations

Lovren, Fina, Yi Pan, Praphulla Chandra Shukla, et al.. (2009). Visfatin activates eNOS via Akt and MAP kinases and improves endothelial cell function and angiogenesis in vitro and in vivo: translational implications for atherosclerosis. American Journal of Physiology-Endocrinology and Metabolism. 296(6). E1440–E1449. 98 indexed citations

10.

Chan, Christopher T., Fina Lovren, Yi Pan, & Subodh Verma. (2009). Nocturnal haemodialysis is associated with improved vascular smooth muscle cell biology. Nephrology Dialysis Transplantation. 24(12). 3867–3871. 11 indexed citations

11.

Teoh, Hwee, Adrian Quan, K. W. Annie Bang, et al.. (2008). Adiponectin deficiency promotes endothelial activation and profoundly exacerbates sepsis-related mortality. American Journal of Physiology-Endocrinology and Metabolism. 295(3). E658–E664. 68 indexed citations

12.

Teoh, Hwee, Adrian Quan, Fina Lovren, et al.. (2008). Impaired endothelial function in C-reactive protein overexpressing mice. Atherosclerosis. 201(2). 318–325. 65 indexed citations

13.

Maitland, Andrew, Paul W.M. Fedak, Aaron S. Dumont, et al.. (2002). Endothelin blockade potentiates endothelial protective effects of ace inhibitors in saphenous veins. The Annals of Thoracic Surgery. 73(4). 1185–1188. 12 indexed citations

14.

Dumont, Aaron S., Fina Lovren, John H. McNeill, et al.. (2001). Augmentation of endothelial function by endothelin antagonism in human saphenous vein conduits. Journal of neurosurgery. 94(2). 281–286. 13 indexed citations

15.

Lovren, Fina & Chris R. Triggle. (2000). Nitric oxide and sodium nitroprusside‐induced relaxation of the human umbilical artery. British Journal of Pharmacology. 131(3). 521–529. 61 indexed citations

16.

Verma, Subodh, Fina Lovren, Aaron S. Dumont, et al.. (2000). Tetrahydrobiopterin improves endothelial function in human saphenous veins. Journal of Thoracic and Cardiovascular Surgery. 120(4). 668–671. 34 indexed citations

17.

Waldron, Gareth, Hong Ding, Fina Lovren, Paul Kubes, & Chris R. Triggle. (1999). Acetylcholine‐induced relaxation of peripheral arteries isolated from mice lacking endothelial nitric oxide synthase. British Journal of Pharmacology. 128(3). 653–658. 114 indexed citations

18.

Lovren, Fina & Chris R. Triggle. (1998). Involvement of nitrosothiols, nitric oxide and voltage-gated K+ channels in photorelaxation of vascular smooth muscle. European Journal of Pharmacology. 347(2-3). 215–221. 34 indexed citations

19.

Lovren, Fina, et al.. (1996). Nitric oxide, a possible mediator of 1,4‐dihydropyridine‐induced photorelaxation of vascular smooth muscle. British Journal of Pharmacology. 118(4). 879–884. 12 indexed citations

20.

Lovren, Fina, et al.. (1990). Synthesis and Antimicrobiological Activity of N‐Aryl‐substituted 2‐Methyl‐3‐carbethoxy‐5‐pyrrolinone Derivatives. Archiv der Pharmazie. 323(11). 901–904. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact